6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HFrEF on GDMT ... outcomes in HFrEF ... on GDMT, with or ... SGLT2 #inhibitors #EBM ... visualabstract #table #CVD
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... used in HFrEF: ... #CKD #HFrEF #management ... #pharmacology # ... cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
/follow‐up of iron ... , haemoglobin; HFrEF ... Management #Diagnosis #HFrEF ... #sCHF #HeartFailure ... #Cardiology #Indications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... ) Treatment - GDMT ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HFrEF #Pharmacology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... diagnosis #management #cardiology